Cargando…

Ethical tradeoffs in SARS-CoV-2 vaccine development: Assuring fair availability for low-income countries

Detalles Bibliográficos
Autor principal:	Gurwitz, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9756569/ https://www.ncbi.nlm.nih.gov/pubmed/33546810 http://dx.doi.org/10.1016/j.vaccine.2021.01.015

Ejemplares similares

SARS-CoV-2 testing in low- and middle-income countries: availability and affordability in the private health sector
por: Faust, Lena, et al.
Publicado: (2020)

SARS-CoV-2: an occupational hazard presenting challenges for low- and middle-income countries
por: Duncan, Jacqueline P, et al.
Publicado: (2021)

COVID-19 booster vaccination has not decreased access for low-income countries
por: Kalmar, C.L., et al.
Publicado: (2022)

Inspiring academia in low- and middle-income countries
por: Vacek, Adam, et al.
Publicado: (2023)

Seroprevalence of SARS-CoV-2 antibodies in low-income university students
por: Araújo, Adriano Antunes de Souza, et al.
Publicado: (2021)

Ethical and methodological considerations on conducting clinical research in poor and low-income countries: Viewpoint of the authors of the BEST TRIP ICP randomized trial in Latin America
por: Chesnut, Randall M., et al.
Publicado: (2015)

Availability of monkeypox vaccinations for low and middle-income countries: Challenges and recommendations
por: Farahat, Ramadan Abdelmoez, et al.
Publicado: (2022)

Fair or foul?
por: Grover, Neeta Dhar
Publicado: (2013)

Low- and middle- income countries have a different illness profile
por: Gupta, Harish, et al.
Publicado: (2021)

Continuous Surveys and Quality Management in Low-Income Countries: A Good Idea
Publicado: (2010)

Issues of Renal Replacement Therapy in Elders Living Low-Income African Countries
por: Seck, Sidy Mohamed
Publicado: (2012)

Letter to the Editor: COVID-19 & Neurosurgical Training in Low- and Middle-Income Countries
por: Kanmounye, Ulrick Sidney, et al.
Publicado: (2020)

Early phases of COVID-19 management in a low-income country: Bangladesh
por: Monjur, Mohammad R., et al.
Publicado: (2020)

Molecular and computational research in low- and middle-income countries: Development is close at hand
por: Pérez-Fontalvo, Nathalie Marina, et al.
Publicado: (2021)

The impact of article processing charge waiver on conducting research in low-income countries
por: Abdul Baki, M-Nasan, et al.
Publicado: (2021)

Societal challenges facing neurosurgeons in low- and middle-income countries: Iraq as an example
por: Ismail, Mustafa, et al.
Publicado: (2023)

Reply to: comment on increased reliance on physician assistants: an access-quality tradeoff?
por: Walia, Bhavneet, et al.
Publicado: (2023)

Emergency care research ethics in low-income and middle-income countries
por: Millum, Joseph, et al.
Publicado: (2019)

International cooperation to fight cancer’s late-stage presentation in low- and middle-income countries
por: Henke, Oliver, et al.
Publicado: (2023)

Chargeless/Free Availability of Medical Literature: The Ethical Need for Development of Global Healthcare
por: Deshpande, Prasanna R, et al.
Publicado: (2012)

Quality assurance of medicines supplied to low-income and middle-income countries: poor products in shiny boxes?
por: Nebot Giralt, A, et al.
Publicado: (2017)

Quality assurance systems of pharmaceutical distributors in low-income and middle-income countries: weaknesses and ways forward
por: Nebot Giralt, Ariadna, et al.
Publicado: (2020)

Rapid SARS-CoV-2 inactivation by commonly available chemicals on inanimate surfaces
por: Gerlach, M., et al.
Publicado: (2020)

SARS-CoV-2 serosurveys in low-income and middle-income countries
por: Mugunga, Jean Claude, et al.
Publicado: (2021)

Are We Asking All the Right Questions About Quality of Care in Low- and Middle-Income Countries?
por: Topp, Stephanie M., et al.
Publicado: (2018)

Improving access to affordable quality-assured inhaled medicines in low- and middle-income countries
por: Stolbrink, M., et al.
Publicado: (2022)

Editorial: Pharmacometrics—tools to assure optimal medicine use in low- and middle-income countries
por: Abulfathi, Ahmed A., et al.
Publicado: (2022)

Europe should lead in coordinated procurement of quality-assured medicines for programmes in low-income and middle-income countries
por: Perrin, Christophe, et al.
Publicado: (2020)

Insulin prices, availability and affordability in 13 low-income and middle-income countries
por: Ewen, Margaret, et al.
Publicado: (2019)

Speakers from low- and middle-income countries should have a greater voice at ESCMID conferences
por: Mendelson, Marc
Publicado: (2021)

Radiation Therapy for Prostate Cancer: Challenges Facing Low-Middle Income Countries During COVID Pandemic
por: Abu-Hijlih, Ramiz, et al.
Publicado: (2022)

Challenges in maintaining oxygen saturation in pregnant individuals residing in low- and middle-income countries: a response
por: Eid, Joe, et al.
Publicado: (2023)

FAIR chemical structures in the Journal of Cheminformatics
por: Schymanski, Emma L., et al.
Publicado: (2021)

The ethics of COVID-19 vaccine distribution
por: Nichol, Ariadne A., et al.
Publicado: (2021)

Pesticide exposures and children's risk tradeoffs.
por: Charnley, Gail
Publicado: (2003)

So much at stake: Ethical tradeoffs in accelerating SARSCoV-2 vaccine development
por: Grady, Christine, et al.
Publicado: (2020)

Leukocytoclastic Vasculitis and SARS-COV-2 Vaccination
por: Sriwijitalai, Won, et al.
Publicado: (2022)

Esophagitis and SARS-CoV-2 vaccine
por: Sriwijitalai, Won, et al.
Publicado: (2023)

The Importance of Quality Assurance and Quality Improvement in Low- and Middle-Income Settings
por: Bhat, Lipika, et al.
Publicado: (2021)

COVID-19 pandemic and management of patients with chronic neurological conditions in low-middle income countries: the added burden
por: Hazim, Asmaa, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_emmo3j90g7ss40dcdt2k1iaaii